[New York, N.Y., June 1, 2023] – Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery and development company, will exhibit at the BIO International Convention among 4,000+ best and brightest biotechnology and pharma companies from 60+ countries. The Convention attracts 14,000+ attendees for intensive networking and partnership opportunities through 130+ interactive sessions across four days.
Meet CEO Jongsun Jung at our BOOTH #2785,
the BIO International Convention
The Syntekabio team, led by CEO Jong-sun Jung, is looking forward to connecting with industry innovators and business leaders to build synergy through sharing expert insight and knowledge. Meet with us to learn about our latest one-stop AI drug discovery solution STB CLOUD, and envision how Syntekabio’s supercomputing-backed AI platforms can transform your business.
WHAT: The BIO International Convention
DATE: Monday, June 5 – Thursday, June 8, 2023
TIME: 8:00 am – 5:00 pm
WHERE:
Booth #2785 (between the BIO Lounge and the Seoul National University R&DB Foundation), Boston Convention and Exhibition Center, 415 Summer St, Boston, MA 02210 (the Seaport District of Boston, MA)
NOTES: Syntekabio CEO Jongsun Jung and his team of researchers are available onsite. To arrange a meeting, contact Ellie Woo at
ellie.woo@syntekabio.com or +1 (917) 257-4533. For general inquiries on our services, email Syntekabio’s New York office at
admin.usa@syntekabio.com.
